MTOR and B-cell non-Hodgkin lymphoma: Overall, our data indicate that AGN/decursin can efficiently block Myc expression by downregulating PI3K/AKT/mTOR and MAPK signaling pathways, critical downstream mediators of BCR, and exert synergistic effects against B-cell lymphoma when combined with Myc inhibitors.